Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers.-论文-万方医学网

作者： Libo,Yang ^[1] ; Feng,Ye ^[2] ; Longlong,Bao ^[2] ; Xiaoyan,Zhou ^[3] ; Zhe,Wang ^[4] ; Peizhen,Hu ^[5] ; Nengtai,Ouyang ^[3] ; Xiaojuan,Li ^[4] ; Yi,Shi ^[5] ; Gang,Chen ^[6] ; Peiyi,Xia ^[6] ; Meiying,Chui ^[7] ; Wencai,Li ^[7] ; Ying,Jia ^[8] ; Yueping,Liu ^[8] ; Junjun,Liu ^[9] ; Junyi,Ye ^[10] ; Zhe,Zhang ^[9] ; Hong,Bu ^[10]

作者单位： Department of Pathology, West China Hospital of Sichuan University, Chengdu, China. ^[1] Laboratory of Pathology, West China Hospital of Sichuan University, Chengdu, China. ^[2] Department of Pathology, Shanghai Cancer Center, Fudan University, Shanghai, China. ^[3] Department of Oncology, Shanghai Medical College, Shanghai, China. ^[4] Institute of Pathology, Fudan University, Shanghai, China. ^[5] Department of Pathology, Xijing Hospital and School of Basic Medicine, Air Force Medical University, Xi'an, China. ^[6] Cellular & Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. ^[7] Department of Molecular Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China. ^[8] Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. ^[9] Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, China. ^[10] Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. ^[11] Burning Rock Biotech, Guangzhou, China. ^[12]

主题词成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);I类磷脂酰肌醇3-激酶类(Class I Phosphatidylinositol 3-Kinases);细胞周期蛋白D1(Cyclin D1);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因扩增(Gene Amplification);遗传变异(Genetic Variation);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);中年人(Middle Aged);突变(Mutation);肿瘤辅助疗法(Neoadjuvant Therapy);信号传导(Signal Transduction);治疗结果(Treatment Outcome);肿瘤负荷(Tumor Burden);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)

DOI 10.1111/cas.13976

PMID 30776175

发布时间 2021-01-09

检索历史清除

Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers.

Cancer science

相似文献

Cancer science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers.

Cancer science

相似文献

Cancer science

相关期刊

检索历史清除